This year’s digital AMR Conference will be an international forum to discuss AMR in the context of COVID-19 and beyond.

CARB-X speakers include Kevin Outterson, Executive Director, Erin Duffy, Chief of Research and Development, and Betsy Wonderly Trainor, Alliance Director.

The current global health crisis caused by COVID-19 shows more than ever the importance of infectious diseases expertise and the high need for further fighting against antimicrobial resistance (AMR). A cross-sectoral international dialogue with all stakeholders involved will be crucial to help implement innovative therapies and diagnostics in the clinical practice globally.

Together with our supporters – among others our major partner, the BEAM Alliance – the AMR Conference will continue to provide a (virtual) platform for those debates bringing together stakeholders from industry, SMEs, start-ups, academia, clinics, investors, public institutions and policy. Within our digital AMR Conference Week in August, we want to catch up discussing the challenges of bringing new antimicrobial treatments and diagnostics into the market and as a result, help to establish a post-COVID policy roadmap on AMR.

Five days of insights and networking for the global AMR community: Each conference day will cover a focus topic with selected LIVE sessions and high-level panels. Additionally, you will be able to explore scientific poster presentations and participate in virtual 1:1 meetings throughout the whole week and to engage within our new digital AMR stakeholder platform which is currently being set up.